Motomichi Kosuga

Molecular diagnosis of 65 families with mucopolysaccharidosis type II (Hunter syndrome) characterized by 16 novel mutations in the IDS gene: Genetic, pathological, and structural studies on iduronate-2-sulfatase

Motomichi Kosuga, Ryuichi Mashima, Asami Hirakiyama et al. · Molecular Genetics and Metabolism · 2016 · 74 citations

Rare Diseases, Mendelian Disorder, Genetic Disorder +10

Effects of idursulfase enzyme replacement therapy for Mucopolysaccharidosis type II when started in early infancy: Comparison in two siblings

Go Tajima, Nobuo Sakura, Motomichi Kosuga et al. · Molecular Genetics and Metabolism · 2013 · 62 citations

Inherited Metabolic Disease, Pediatrics, Pathology +4

Enzyme replacement therapy attenuates disease progression in two Japanese siblings with mucopolysaccharidosis type VI

Mahoko Furujo, Toshihide Kubo, Motomichi Kosuga et al. · Molecular Genetics and Metabolism · 2011 · 60 citations

Enzyme Replacement Therapy, Immunodeficiencies, Pathogenesis +5

A molecular analysis of the GAA gene and clinical spectrum in 38 patients with Pompe disease in Japan

Yasuyuki Fukuhara, Naoko Fuji, Narutoshi Yamazaki et al. · Molecular Genetics and Metabolism Reports · 2017 · 53 citations · Full text

Overexpression of Bcl-2 protects human hepatoma cells from Fasantibody-mediated apoptosis

Masahīko Takahashi, Hidetsugu Saito, Torayuki Okuyama et al. · Journal of Hepatology · 1999 · 51 citations

Hepatology, Cell Regulation, Hepatocellular Carcinoma +13